Biofrontera AG (B8F.DE) XETRA

6.80

+6.48(+2000.00%)

Updated at May 13, 2024 05:36PM

Currency In EUR

Valuation

Market Cap589.58M
Enterprise Value587.64M
P/E Ratio-0.41
PEG Ratio0.01
Price/Sales Ratio0.21
Price/Book Ratio-1.44
Enterprise/Revenue0.16
Enterprise/EBITDA-0.4

Fiscal Year

Fiscal YearDecember 31, 2023
Most Recent QuarterMarch 31, 2024

Profitability

Profit Margin-0.42
Operating Margin-0.42

Management Effectiveness

Return On Assets-0.82
Return On Equity-11.51

Income Statement

Revenue32.25M
Revenue/Share4.19
Gross Profit25.37M
EBITDA5.57M
Net Income-369,000
Diluted EPS-0.01

Balance Sheet

Total Cash3.29M
Total Cash/Share0.78
Total Debt1.04M
Total Debt/Equity-1.07
Current Ratio0.96
Book Value Per Share-0.5

Price History

52-Week Change680.28
52-Week High22.58
52-Week Low0.3
Moving Average 50 Days6.53
Moving Average 200 Days9.19

Statistics

Average Volume605
Shares Outstanding3.04M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split Factor1:21
Last Split DateMay 14, 2024